Abstract Details

Title Comparison of Clinical and Radiological Characteristics of Warfarin versus Novel Oral Anticoagulant Related Intracerebral Hemorrhages

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) P1 - (-)

Poster/Presentation
Number 251

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Malgorzata Miller, MD (Corewell Health) PRESENTER	Dr. Miller has nothing to disclose.
Nils Henninger, MD, PhD, FANA (UMass Memorial Medical Center)	Dr. Henninger has stock in United Health. Dr. Henninger has stock in Novo Nordisk. Dr. Henninger has stock in Elli Lilly. Dr. Henninger has stock in Kenvue. The institution of Dr. Henninger has received research support from DoD. The institution of Dr. Henninger has received research support from NIH. Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Verge Genomics. Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Myrobalan Inc.